Boc-N-Me-D-Arg(Tos)-OH

Boc-N-Me-D-Arg(Tos)-OH is a Boc-protected, N-methylated D-arginine derivative bearing a tosyl-protected guanidinium side chain. This stereochemically defined, protected amino acid building block is engineered for peptide coupling workflows where the D-configuration and N-methyl substitution help tune backbone conformation and proteolytic stability, while the Tos group maintains guanidine chemoselectivity during assembly. The reagent form is commonly used in peptide synthesis and medicinal chemistry programs that require controlled incorporation of modified arginine residues.

1. D-Arginine Peptide Building Block

Boc-N-Me-D-Arg(Tos)-OH is used by peptide synthesis groups to introduce a D-arginine residue with an N-methylated backbone into custom peptides and peptidomimetics. The Boc group provides an N-terminal protecting strategy compatible with standard protected-amino-acid coupling sequences, while the N-methyl functionality is leveraged to modulate local sterics and hydrogen-bonding patterns in the growing chain. The Tos-protected guanidinium side chain helps prevent undesired side reactions during peptide assembly, enabling downstream deprotection and controlled generation of the cationic arginine functionality in the final target.

2. Peptidomimetic Medicinal Chemistry

Boc-N-Me-D-Arg(Tos)-OH supports medicinal chemistry teams developing constrained or protease-resistant peptidomimetics where arginine-like side-chain presentation and backbone modification are required. Incorporation of a D-configuration together with N-methylation is frequently used to influence conformational preferences and improve chemical robustness of peptide-like scaffolds during lead optimization. In these workflows, the protected guanidine (Tos) and Boc protection allow reliable stepwise synthesis of analog series, including analogs used for structure-activity relationship studies and binding/functional assays in chemical biology settings.

3. Solid-Phase Peptide Synthesis Modules

Boc-N-Me-D-Arg(Tos)-OH is employed as a protected amino acid module in solid-phase peptide synthesis workflows to build sequences containing modified arginine residues with defined stereochemistry. Researchers use this reagent when they need to maintain the guanidinium side chain in a protected state throughout chain elongation, reducing the risk of side reactions and improving coupling consistency across longer or more complex sequences. After peptide assembly, the protected arginine functionality can be unveiled as part of the final global deprotection strategy, providing access to the cationic side chain needed for subsequent purification, characterization, or biological testing of the assembled peptide.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling